Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at having imatinib for 3 or 5 years for gastrointestinal stromal tumour (SSG XXII)

Overview

Cancer types:

Sarcoma, Soft tissue sarcoma

Status:

Closed

Phase:

Phase 3

Details

This trial is for people with gastrointestinal stromal tumour (GIST) who have had surgery and taken imatinib for 3 years.

Cancer Research UK supports this trial.

Recruitment start: 11 January 2017

Recruitment end: 30 September 2022

How to join

Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Ramesh Bulusu

Supported by

Cambridge University Hospitals NHS Foundation Trust

Cancer Research UK

Novartis

Scandinavian Sarcoma Group (SSG)

GIST Cancer UK

Other information

This is Cancer Research UK trial number CRUK/15/073

Last reviewed: 11 Sept 2024

CRUK internal database number: 13390

Help and support